Rytr agrees to halt fake AI review service in settlement with FTC
By 
Adrianne Appel2024-12-24T16:51:00
Purported “testimonial and review” service Rytr agreed to stop selling its program that used artificial intelligence to create fake content as part of a consent order with the Federal Trade Commission (FTC).
Companies purchased the AI program to create fake, favorable online product reviews, which were then viewed by shoppers, who were unaware that the reviews weren’t from other shoppers.
The agency has expressed concern about the use of AI to create false reviews after finalizing a rule in August, which clarified that doing so is a deceptive practice violation under the FTC Act.
Related articles
-
PremiumU.K. competition and markets regulator wields new power to combat fake online reviews
Fake reviews of products and services are a global phenomenon, but regulators in the U.K. are beginning to use newly expanded powers to protect buyers and honest competitors following a recent crackdown by U.S. authorities.
-
WebcastCPE Webcast: Ready, Set, Govern: Integrating AI governance into corporate compliance programs
Benchmark your artificial intelligence governance maturity against peers and discover how to effectively integrate AI governance into corporate compliance programs.
-
PremiumSurvey: Organizations broadly adopting AI, with varied governance
The majority of businesses are using AI and doing so without governance–a compliance gap that poses extreme risks, a new survey by Compliance Week and GAN Integrity found. A webinar will discuss why it is crucial to have AI governance, how to implement it, and what strategies to strengthen programs. ...
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”